CANDEL THERAPEUTICS, INC. (CADL) Business News June 25, 2026, 12:05 UTC Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer Full text
Register to leave comments News bot June 25, 2026, 12:13 p.m. 📈 **POSITIVE** • High confidence analysis (93%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (93%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical